Digital Health in Neurology Market By Component (Software, Hardware); By Indication (Alzheimer’s Disease, Parkinson’s Disease); By End User (Patients, Providers); By Geography – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Digital Health in Neurology Market size was valued USD 36,000 million in 2024 and is anticipated to reach USD 172,096 million by 2032, at a CAGR of 21.6% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Digital Health in Neurology Market Size 2024
USD 36,000 Million
Digital Health in Neurology Market, CAGR
21.6%
Digital Health in Neurology Market Size 2032
USD 172,096 Million
The digital health in neurology market is led by companies such as Teladoc Health, Inc., Omada Health Inc., Blackrock Neurotech, Akili, Inc., AppliedVR, Inc., Neofect Co., Ltd., Proteus Digital Health, Inc., BigHealth, Cognivive, Inc., and AdvancedMD, Inc. These players focus on digital therapeutics, tele-neurology, neurorehabilitation, and brain-computer interface technologies to enhance patient care. Teladoc Health and Omada Health dominate the tele-neurology and behavioral health segments through AI-enabled platforms and remote monitoring tools. North America leads the global market with a 38% share, driven by robust digital infrastructure, widespread telemedicine adoption, and strong research funding for neurological innovation.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Digital Health in Neurology Market was valued at USD 36,000 million in 2024 and is projected to reach USD 172,096 million by 2032, growing at a CAGR of 21.6%.
Rising prevalence of neurological disorders and growing demand for AI-driven remote monitoring systems are driving market expansion.
Increasing adoption of digital therapeutics, wearable sensors, and tele-neurology solutions marks a key market trend across healthcare systems.
The market remains competitive with players focusing on AI integration, digital biomarkers, and virtual rehabilitation platforms to enhance patient outcomes.
North America leads the global market with a 38% share, while the software segment dominates with a 47% contribution, supported by advanced healthcare infrastructure and rapid digital adoption.
Market Segmentation Analysis:
By Component
Software dominated the digital health in neurology market, holding a 47% share in 2024. The segment’s growth is driven by rising adoption of AI-based diagnostic tools, mobile health apps, and remote monitoring platforms. Software solutions enable continuous tracking of neurological parameters, data analytics, and early detection of cognitive decline. For instance, Neurotrack’s digital memory assessment tool provides real-time analysis of eye movement data, improving early Alzheimer’s detection accuracy. The integration of predictive analytics and cloud-based platforms supports clinical decision-making and enhances personalized neurological care delivery.
For instance, Teladoc Health, Inc.’s integrated platform leverages the Livongo system’s ability to connect with more than 400 FDA-cleared connected devices to capture over 3 billion biometric data points annually, which are used to provide personalized insights and coaching for chronic conditions like diabetes and hypertension.
By Indication
Alzheimer’s disease led the market with a 36% share in 2024 due to the high global disease prevalence and increasing demand for remote cognitive assessment tools. Digital platforms aid in early diagnosis, behavioral monitoring, and treatment adherence. For instance, Eisai and Biogen’s digital platform integrates AI algorithms to assess cognitive function, enabling more precise tracking of disease progression. The rising use of wearables, tele-neurology consultations, and memory assessment applications continues to drive adoption across healthcare systems focused on elderly populations.
For instance, Blackrock Neurotech’s core “Utah Array” implant supports up to 96 electrodes per array and 1,024 channels per system.In a clinical context, that array has been implanted in 29 human patients for up to 7 years as part of BCI systems targeting neural disorders.
By End-user
Providers accounted for the dominant 42% share of the market in 2024, supported by increasing implementation of digital tools in hospitals, clinics, and rehabilitation centers. These solutions streamline diagnosis, treatment planning, and patient engagement through remote monitoring and telemedicine integration. For instance, Cleveland Clinic’s remote neurology program allows physicians to track Parkinson’s symptoms using motion sensors, improving patient management efficiency. The growing focus on cost reduction, clinical workflow automation, and real-time data insights further enhances digital health adoption among neurological care providers.
Key Growth Drivers
Rising Prevalence of Neurological Disorders
The increasing incidence of neurological diseases such as Alzheimer’s, Parkinson’s, and multiple sclerosis is driving demand for digital health technologies. Remote monitoring platforms, wearable sensors, and tele-neurology solutions enable continuous tracking of patient health and early intervention. For instance, wearable EEG headsets like EMOTIV EPOC+ capture brainwave data with 14 sensors, enhancing clinical decision-making. As global neurological cases rise, healthcare providers are adopting digital solutions to improve diagnosis accuracy, reduce hospital visits, and support long-term disease management.
For instance, Omada Health reports that it has enrolled over 1 million members total, enabling its AI and analytics platform to train on that dataset for chronic-care programs.
Advancements in Artificial Intelligence and Data Analytics
Artificial intelligence and predictive analytics are transforming neurology care by enabling precise diagnosis and personalized treatment. Machine learning models analyze imaging data and neurological patterns to detect diseases at early stages. For example, BioMind’s AI algorithm achieved 94% accuracy in identifying brain tumors from MRI scans, surpassing human specialists. The integration of AI in neurology supports efficient decision-making, automates clinical workflows, and enhances patient outcomes. Continuous innovation in data-driven platforms is expanding clinical adoption worldwide.
For instance, Akili’s digital therapeutic platform, built on its proprietary Selective Stimulus Management Engine (SSME™), was evaluated in a Phase 3 clinical trial involving 164 paediatric patients aged 6-17 treating ADHD (Japanese version SDT-001) using approximately 25 minutes daily for 6 weeks, achieving statistically significant improvement in the ADHD-RS-IV Inattention score versus control (p < 0.05).
Expansion of Tele-Neurology and Remote Patient Monitoring
The growing use of telemedicine and connected health devices supports remote neurological assessments and follow-ups. Digital platforms bridge accessibility gaps for patients in rural and underserved regions. For instance, Philips’ cloud-based tele-neurology solution enables real-time collaboration between specialists and local clinicians, improving stroke care response time. Remote patient monitoring systems enhance treatment adherence, reduce costs, and ensure timely medical intervention. The expanding telehealth infrastructure is strengthening the overall digital transformation in neurology care.
Key Trends & Opportunities
Integration of Digital Biomarkers in Neurology
Digital biomarkers are emerging as valuable tools for tracking neurological activity through smartphones, wearables, and sensors. These biomarkers provide continuous, objective insights into motor function, cognition, and behavior. For example, Roche’s smartphone-based app uses accelerometer and voice data to monitor multiple sclerosis symptoms remotely. Such innovations support precision medicine, facilitate clinical trials, and improve patient engagement. The increasing integration of digital biomarkers represents a major opportunity for early disease detection and personalized therapeutic strategies.
For instance, Neofect’s Smart Pegboard device recorded a completion time of ~170 seconds (mean) across 19 hemiplegic stroke patients during a 4-week, 30-minute per session protocol.
Growing Focus on Personalized Neurological Therapies
The shift toward individualized treatment plans is creating new opportunities in digital neurology. AI-powered platforms analyze patient-specific data to tailor medication, rehabilitation, and cognitive therapy programs. For instance, MindMaze’s digital neuro-rehabilitation system customizes recovery exercises using real-time motion feedback. This trend enhances treatment adherence and accelerates recovery outcomes. Personalized digital tools are expected to dominate future neurological care by optimizing therapy effectiveness and improving quality of life for patients with chronic neurological conditions.
For instance, AppliedVR’s immersive therapeutic platform RelieVRx® (formerly EaseVRx®) underwent a pivotal home-based programme of 56 sessions for adults with chronic lower back pain, where participants in one large RCT completed an average of 37.6 sessions out of the 56.
Key Challenges
Data Privacy and Security Concerns
The growing use of connected devices and cloud-based platforms raises concerns about data privacy in digital neurology. Sensitive neurological health information requires robust cybersecurity frameworks to prevent breaches and unauthorized access. For example, the U.S. Department of Health reported over 500 healthcare data breaches in 2024, affecting millions of records. Ensuring compliance with regulations such as HIPAA and GDPR is critical for maintaining patient trust. Lack of standardized encryption and authentication protocols remains a significant challenge for developers and providers.
Limited Reimbursement and Regulatory Barriers
Despite strong innovation, reimbursement limitations and fragmented regulatory approvals hinder digital adoption in neurology. Many healthcare systems lack structured reimbursement models for tele-neurology consultations and digital therapeutic tools. For instance, less than 35% of global insurers currently cover remote neurological monitoring programs. The absence of clear guidelines for clinical validation and data integration slows product commercialization. Overcoming these barriers requires coordinated efforts between regulators, payers, and healthcare providers to establish sustainable digital neurology ecosystems.
Regional Analysis
North America
North America dominated the digital health in neurology market with a 38% share in 2024. The region benefits from advanced healthcare infrastructure, high adoption of tele-neurology, and increasing prevalence of neurological disorders. Strong investment in AI-driven diagnostics and remote monitoring platforms supports market expansion. For instance, the U.S. National Institutes of Health (NIH) allocated over USD 2.3 billion to neurological research programs, enhancing digital innovation. Favorable reimbursement policies and widespread integration of digital platforms across hospitals and clinics further strengthen the regional market’s leadership.
Europe
Europe held a 29% share of the digital health in neurology market in 2024, driven by rising government initiatives promoting e-health and clinical digitization. The region’s healthcare systems actively adopt AI-based neuroimaging tools, teleconsultations, and remote rehabilitation programs. For example, the European Commission’s Horizon Europe program funds AI-based neurological research exceeding EUR 1 billion. Countries like Germany, the U.K., and France lead digital implementation through strong policy frameworks and robust data security laws. The presence of established technology providers and growing use of digital biomarkers drive continuous innovation.
Asia-Pacific
Asia-Pacific accounted for a 22% share in 2024 and is the fastest-growing region due to expanding healthcare digitization and rising neurological disease burden. Governments in China, Japan, and India are investing in telemedicine and wearable monitoring technologies to improve patient access. For instance, Japan’s Ministry of Health launched nationwide tele-neurology pilots using connected EEG devices for stroke detection. Growing smartphone penetration, AI healthcare startups, and supportive policy reforms fuel adoption. Increasing awareness and affordability of digital tools continue to boost regional market growth.
Latin America
Latin America captured an 7% share of the market in 2024, supported by growing telehealth penetration and expanding neurological care infrastructure. Countries like Brazil and Mexico are integrating mobile health apps and cloud-based solutions for early disease detection. For instance, Brazil’s public hospitals implemented digital platforms to monitor epilepsy patients remotely, improving continuity of care. Rising investments in connected health systems and training initiatives for digital literacy enhance adoption. However, uneven connectivity and regulatory disparities remain challenges for broader market expansion in the region.
Middle East & Africa
The Middle East & Africa region accounted for a 4% share in 2024, showing steady adoption of digital neurology solutions. The Gulf Cooperation Council (GCC) countries are leading initiatives to develop smart healthcare systems and tele-neurology programs. For example, Saudi Arabia’s Vision 2030 plan prioritizes digital transformation in neurological care through AI-assisted diagnostics. Partnerships between hospitals and technology firms are improving remote monitoring and treatment access. Despite infrastructure constraints in parts of Africa, ongoing digital health investments and public-private collaborations are gradually expanding regional participation.
Market Segmentations:
By Component:
Software
Hardware
By Indication:
Alzheimer’s disease
Parkinson’s disease
By End User:
Patients
Providers
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
The competitive landscape of the Digital Health in Neurology Market features major players such as Teladoc Health, Inc., Blackrock Neurotech, Omada Health Inc., Akili, Inc., Neofect Co., Ltd., AppliedVR, Inc., Proteus Digital Health, Inc., BigHealth, Cognivive, Inc., and AdvancedMD, Inc. The digital health in neurology market is characterized by strong competition among technology-driven healthcare innovators focusing on AI, telemedicine, and digital therapeutics. Companies are investing in advanced neurodiagnostic tools, wearable devices, and software platforms that enable real-time patient monitoring and personalized treatment. The growing emphasis on clinical validation, regulatory approvals, and data interoperability is shaping competitive differentiation. Strategic collaborations with healthcare providers and research institutions are enhancing product scalability and global reach. Additionally, advancements in digital biomarkers, virtual rehabilitation, and remote cognitive assessment tools are creating new avenues for growth, driving continuous innovation across the market landscape.
In February 2024, AdvancedMD announced over 30 updates to its EHR, practice management, and patient engagement tools. The release focused on enhancing operational agility and improving billing capabilities to optimize practice efficiency, ensure financial stability, and drive success and sustainability in healthcare practices.
In February 2024, Aptar Digital Health, a division of AptarGroup, Inc., and Biogen Inc., reached an enterprise agreement to manage and create digital health solutions for neurological and uncommon disorders.
In October 2023, The Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostic Accelerator (DxA) launched SpeechDx, a longitudinal study to create the largest repository of voice and speech data to help speed up the diagnosis, detection, and monitoring of Alzheimer’s disease.
In August 2023, Aspen Neuroscience partnered with Emerald Innovations and Rune Labs to integrate digital health (DHT) methods in the company’s Trial-Ready Screening Cohort Study launched in 2022. The study is developing a cell therapy to cure Parkinson’s disease.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The research report offers an in-depth analysis based on Component, Indication, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
Increasing integration of AI-driven diagnostic platforms will enhance precision and early disease detection.
Expansion of tele-neurology services will improve access to neurological care in remote areas.
Growing adoption of wearable sensors will enable continuous monitoring of patient health data.
Advancements in digital biomarkers will support personalized therapy and clinical decision-making.
Collaboration between tech firms and healthcare providers will accelerate digital innovation and scalability.
Regulatory frameworks will evolve to improve reimbursement and data standardization for digital tools.
Integration of cloud-based platforms will streamline real-time neurological data management.
Virtual and augmented reality therapies will gain traction in neuro-rehabilitation and cognitive recovery.
Increased investment in digital clinical trials will drive validation of new neurological technologies.
Rising patient awareness and acceptance of digital health solutions will fuel long-term market growth.
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope 2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology 3. Executive Summary 4. Introduction
4.1. Overview
4.2. Key Industry Trends 5. Global Digital Health in Neurology Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast 6. Market Breakup by Component
6.1. Software
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Hardware
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity 7. Market Breakup by Indication
7.1. Alzheimer’s Disease
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Parkinson’s Disease
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity 8. Market Breakup by End User
8.1. Patients
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Providers
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity 9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast 10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats 11. Value Chain Analysis 12. Porters Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes 13. Price Analysis 14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. Teladoc Health, Inc.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. Financials
14.3.1.4. SWOT Analysis
14.3.2. Blackrock Neurotech
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. Financials
14.3.2.4. SWOT Analysis
14.3.3. Omada Health Inc.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. Financials
14.3.3.4. SWOT Analysis
14.3.4. Akili, Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. Financials
14.3.4.4. SWOT Analysis
14.3.5. Neofect Co., Ltd.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. Financials
14.3.5.4. SWOT Analysis
14.3.6. AppliedVR, Inc.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. Financials
14.3.6.4. SWOT Analysis
14.3.7. Proteus Digital Health, Inc.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. Financials
14.3.7.4. SWOT Analysis
14.3.8. BigHealth
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. Financials
14.3.8.4. SWOT Analysis
14.3.9. Cognivive, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. Financials
14.3.9.4. SWOT Analysis
14.3.10. AdvancedMD, Inc.
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. Financials
14.3.10.4. SWOT Analysis 15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for the Digital Health in Neurology Market, and what is its projected size in 2032?
The market was valued at USD 36,000 million in 2024 and is expected to reach USD 172,096 million by 2032.
At what Compound Annual Growth Rate is the Digital Health in Neurology Market projected to grow between 2025 and 2032?
The market is anticipated to grow at a CAGR of 21.6% during the forecast period.
Which Digital Health in Neurology Market segment held the largest share in 2024?
The software segment dominated with a 47% share, driven by AI-based diagnostic tools and remote monitoring platforms.
What are the primary factors fueling the growth of the Digital Health in Neurology Market?
Rising neurological disorders, AI advancements, and increased tele-neurology adoption are the major growth drivers.
Who are the leading companies in the Digital Health in Neurology Market?
Key players include Teladoc Health, Omada Health, Blackrock Neurotech, Akili, AppliedVR, and Neofect.
Which region commanded the largest share of the Digital Health in Neurology Market in 2024?
North America led the market with a 38% share, supported by advanced digital infrastructure and strong telehealth adoption.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
Companion Animal Rehabilitation Services Market size was valued at USD 577 million in 2024 and is anticipated to reach USD 1,385 million by 2032, at a CAGR of 11.57% during the forecast period.
The Companion Animal Pain Management Market size was valued at USD 1,727 million in 2024 and is anticipated to reach USD 2,753 million by 2032, at a CAGR of 6% during the forecast period.
Companion Animal Healthcare Market size was valued at USD 113,679 million in 2024 and is anticipated to reach USD 195,322 million by 2032, at a CAGR of 7% during the forecast period.
The Companion Animal Ear Infection Treatment Market size was valued at USD 649 million in 2024 and is anticipated to reach USD 1,193 million by 2032, at a CAGR of 7.91% during the forecast period.
The Companion Animal Drugs Market size was valued at USD 23,273 Million in 2024 and is anticipated to reach USD 38,807 Million by 2032, at a CAGR of 6.6% during the forecast period.
The Companion Animal Arthritis Market size was valued at USD 3,091 Million in 2024 and is anticipated to reach USD 5,311 Million by 2032, at a CAGR of 7% during the forecast period.
The Companion Animal Diagnostic Market size was valued at USD 5,336 Million in 2024 and is anticipated to reach USD 10,829 Million by 2032, at a CAGR of 9.25% during the forecast period.
The Androgenetic Alopecia Treatment Market is projected to grow from USD 2,727.27 million in 2024 to an estimated USD 5,123.26 million by 2032, with a compound annual growth rate (CAGR) of 8.2% from 2024 to 2032.
The Animal Pregnancy Kit Market is projected to grow from USD 49.07 million in 2024 to an estimated USD 68.2 million by 2032, with a compound annual growth rate (CAGR) of 4.2% from 2024 to 2032.
The Antifungal drugs market size was valued at USD 13200.74 million in 2024 and is anticipated to reach USD 17115.94 million by 2032, at a CAGR of 3.3% during the forecast period.
The Annuloplasty System Market was valued at USD 407 million in 2024 and is projected to reach USD 611 million by 2032, expanding at a CAGR of 5.2% during the forecast period.
The Animal Vaccines Market was valued at USD 9,000 million in 2024 and is projected to reach USD 15,120 million by 2032, growing at a CAGR of 6.7% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
